CSX Corporation (CSX) Releases Q4 2025 Earnings: Revenue and Gross Profit Down, EPS Miss; Cash Flow Up

CSX Corporation (CSX) reported fourth-quarter 2025 results with revenue of $3.5 billion (down 0.9% year‑over‑year), gross profit of $1.5 billion (down 6.8%), operating profit of $1.1 billion (up 0.4%), and net income attributable to common shareholders of $720 million (down 1.8%). Diluted earnings per share were $0.39.

Revenue: $3.5 billion (‑0.9% YoY)

Gross profit: $1.5 billion (‑6.8% YoY)

Operating profit: $1.1 billion (+0.4% YoY)

Net income: $720 million (‑1.8% YoY)

Diluted EPS: $0.39

Results trailed expectations: revenue came in below the estimate of $3.6 billion, and diluted EPS missed the estimate of $0.42.

Cash flow and balance-sheet notes: cash from operating activities rose to $1.4 billion (up 30.0% YoY), purchases of property, plant and equipment increased to $677 million (up 31.0%), cash and cash equivalents fell to $670 million (down 28.2%), and total liabilities were about $30.5 billion (up 0.9%).

Operating cash flow showed a meaningful improvement.

Capital spending expanded, signaling continued investment.

Top-line and gross-profit declines point to margin pressure.

EPS was essentially flat but missed analyst expectations.

Liquidity declined while liabilities ticked slightly higher.

Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.

CSX Corporation Insider Trading Activity

CSX Corporation insiders have traded $CSX stock on the open market 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $CSX stock by insiders over the last 6 months:

STEPHEN F ANGEL (President & CEO) purchased 55,000 shares for an estimated $2,027,849
KEVIN S. BOONE (EVP & CCO) sold 31,053 shares for an estimated $1,120,702
MICHAEL S. BURNS (SVP - CLO & Corp Secy) sold 24,249 shares for an estimated $891,393

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

CSX Corporation Hedge Fund Activity

We have seen 776 institutional investors add shares of CSX Corporation stock to their portfolio, and 703 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JPMORGAN CHASE & CO removed 35,423,958 shares (-62.7%) from their portfolio in Q3 2025, for an estimated $1,257,904,748
BANK OF AMERICA CORP /DE/ added 26,711,916 shares (+165.7%) to their portfolio in Q3 2025, for an estimated $948,540,137
CAPITAL INTERNATIONAL INVESTORS removed 16,369,231 shares (-92.0%) from their portfolio in Q3 2025, for an estimated $581,271,392
DEUTSCHE BANK AG\ added 13,736,558 shares (+200.5%) to their portfolio in Q3 2025, for an estimated $487,785,174
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 13,029,232 shares (+73.5%) to their portfolio in Q3 2025, for an estimated $462,668,028
VICTORY CAPITAL MANAGEMENT INC added 10,625,745 shares (+648.4%) to their portfolio in Q3 2025, for an estimated $377,320,204
BALYASNY ASSET MANAGEMENT L.P. added 8,193,101 shares (+inf%) to their portfolio in Q3 2025, for an estimated $290,937,016

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CSX Corporation Congressional Stock Trading

Members of Congress have traded $CSX stock 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $CSX stock by members of Congress over the last 6 months:

SENATOR MARKWAYNE MULLIN sold up to $50,000 on 11/10.
REPRESENTATIVE KEVIN HERN sold up to $50,000 on 10/28.
REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

CSX Corporation Analyst Ratings

Wall Street analysts have issued reports on $CSX in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Barclays issued a "Overweight" rating on 10/20/2025
Jefferies issued a "Buy" rating on 10/17/2025
UBS issued a "Buy" rating on 10/17/2025
Citigroup issued a "Buy" rating on 10/13/2025
Baird issued a "Outperform" rating on 09/26/2025
Wells Fargo issued a "Overweight" rating on 09/25/2025
B of A Securities issued a "Buy" rating on 09/24/2025

To track analyst ratings and price targets for CSX Corporation, check out Quiver Quantitative's $CSX forecast page.

CSX Corporation Price Targets

Multiple analysts have issued price targets for $CSX recently. We have seen 15 analysts offer price targets for $CSX in the last 6 months, with a median target of $40.0.

Here are some recent targets:

Brian Ossenbeck from JP Morgan set a target price of $43.0 on 01/12/2026
Ravi Shanker from Morgan Stanley set a target price of $30.0 on 12/08/2025
Daniel Moore from Baird set a target price of $40.0 on 10/20/2025
Brandon Oglenski from Barclays set a target price of $40.0 on 10/20/2025
Jonathan Chappell from Evercore ISI Group set a target price of $39.0 on 10/17/2025
Stephanie Moore from Jefferies set a target price of $42.0 on 10/17/2025
Jason Seidl from TD Cowen set a target price of $39.0 on 10/17/2025